MarketBeat Instant News Alerts 15 minutes agoAxsome Therapeutics Sees AUVELITY Prescription Surge After Alzheimer’s Agitation LaunchMarketBeatAxsome Therapeutics (NASDAQ:AXSM) executives said growth in new prescriptions for AUVELITY and an expanded sales team are positioning the company for further growth following the drug’s launch for Alzheimer’s disease agitation. Speaking at the UBS Biopharma Conference in London, Chief Financial OffNASDAQ:AXSMRead Axsome Therapeutics Sees AUVELITY Prescription Surge After Alzheimer’s Agitation Launch15 minutes agoWhat H World Group (HTHT) Said on Its Q3 Earnings CallMarketBeatH World Group (NASDAQ:HTHT) raised its full-year revenue growth guidance after reporting higher third-quarter revenue and profit, as expansion of its managed and franchised hotel network helped offset a decline in revenue from leased and owned properties. The hotel operator said group revenue rose NASDAQ:HTHTRead What H World Group (HTHT) Said on Its Q3 Earnings Call15 minutes agoMasTec (NYSE:MTZ) Price Target Cut to $335.00 by Analysts at GuggenheimMarketBeatGuggenheim cut their price target on shares of MasTec from $518.00 to $335.00 and set a "buy" rating on the stock in a report on Monday.NYSE:MTZRead MasTec (NYSE:MTZ) Price Target Cut to $335.00 by Analysts at Guggenheim15 minutes agoArriVent BioPharma (NASDAQ:AVBP) Stock Price Target Lowered at GuggenheimMarketBeatGuggenheim dropped their price target on ArriVent BioPharma from $30.00 to $28.00 and set a "buy" rating for the company in a research report on Monday.NASDAQ:AVBPRead ArriVent BioPharma (NASDAQ:AVBP) Stock Price Target Lowered at Guggenheim15 minutes agoJade Biosciences (NASDAQ:JBIO) Stock Price Target Lowered at GuggenheimMarketBeatGuggenheim decreased their target price on shares of Jade Biosciences from $47.00 to $41.00 and set a "buy" rating on the stock in a research report on Monday.NASDAQ:JBIORead Jade Biosciences (NASDAQ:JBIO) Stock Price Target Lowered at Guggenheim15 minutes agoGuggenheim Issues Positive Forecast for Praxis Precision Medicines (NASDAQ:PRAX) Stock PriceMarketBeatGuggenheim upped their target price on Praxis Precision Medicines from $800.00 to $1,050.00 and gave the company a "buy" rating in a research note on Monday.NASDAQ:PRAXRead Guggenheim Issues Positive Forecast for Praxis Precision Medicines (NASDAQ:PRAX) Stock Price Trending News1StoneX Group Inc. Sells 2,502 Shares of Meta Platforms, Inc. $META2Evolus Eyes 2027 Sculpt Launch as Filler Portfolio Expands and Revenue Grows3What Cerebras Systems (CBRS) Said on Its Q3 Earnings Call4Fermi (NASDAQ:FRMI) Stock Jumps 17.5% - What's Next?5Insider Selling: eBay (NASDAQ:EBAY) SVP Sells 31,000 Shares of Company Stock6BigBear.ai (NYSE:BBAI) Hits New 1-Year Low - Here's Why7Andersen Group Inc. $ANDG Stock Sold by Royce & Associates LP8What Questerre Energy (QEC) Said on Its Q3 Earnings Call All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 5 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Corporate Event Transcript Dividend Earnings Earnings Preview Earnings Transcript Highlights Estimates Guidance Insider Trade Lockup Expiration MarketBeat List Articles Options Price SEC Filing Stock List Stock Split Alert Type Keywords More filters Fewer filters Done 15 minutes agoGuggenheim Has Lowered Expectations for Zevra Therapeutics (NASDAQ:ZVRA) Stock PriceMarketBeatNASDAQ:ZVRARead Guggenheim Has Lowered Expectations for Zevra Therapeutics (NASDAQ:ZVRA) Stock Price19 minutes agoPerspective Therapeutics (NYSEAMERICAN:CATX) Director Acquires $15,000.00 in StockMarketBeatNYSEAMERICAN:CATXRead Perspective Therapeutics (NYSEAMERICAN:CATX) Director Acquires $15,000.00 in Stock19 minutes agoPerspective Therapeutics (NYSEAMERICAN:CATX) Director Robert Williamson III Buys 18,609 Shares of StockMarketBeatNYSEAMERICAN:CATXRead Perspective Therapeutics (NYSEAMERICAN:CATX) Director Robert Williamson III Buys 18,609 Shares of Stock19 minutes agoPerspective Therapeutics (NYSEAMERICAN:CATX) Director Purchases $19,950.00 in StockMarketBeatNYSEAMERICAN:CATXRead Perspective Therapeutics (NYSEAMERICAN:CATX) Director Purchases $19,950.00 in Stock19 minutes agoDynex Capital (NYSE:DX) CEO Acquires $25,740.00 in StockMarketBeatNYSE:DXRead Dynex Capital (NYSE:DX) CEO Acquires $25,740.00 in Stock19 minutes agoInsider Buying: Csquare (NYSE:CSQR) Director Acquires $33,920.00 in StockMarketBeatNYSE:CSQRRead Insider Buying: Csquare (NYSE:CSQR) Director Acquires $33,920.00 in Stock20 minutes agoAbeona Therapeutics (NASDAQ:ABEO) Director Faith Charles Acquires 15,000 Shares of Company StockMarketBeatNASDAQ:ABEORead Abeona Therapeutics (NASDAQ:ABEO) Director Faith Charles Acquires 15,000 Shares of Company Stock20 minutes agoDynex Capital (NYSE:DX) Stock: Insider Byron Boston Acquires 4,965 SharesMarketBeatNYSE:DXRead Dynex Capital (NYSE:DX) Stock: Insider Byron Boston Acquires 4,965 Shares20 minutes agoInsider Selling: Radcom (NASDAQ:RDCM) Director Sells $66,000.00 in StockMarketBeatNASDAQ:RDCMRead Insider Selling: Radcom (NASDAQ:RDCM) Director Sells $66,000.00 in Stock20 minutes agoPureCycle Technologies (NASDAQ:PCT) Chairman Acquires $98,496.00 in StockMarketBeatNASDAQ:PCTRead PureCycle Technologies (NASDAQ:PCT) Chairman Acquires $98,496.00 in Stock20 minutes agoInsider Buying: Amdocs (NASDAQ:DOX) Director Purchases $102,239.47 in StockMarketBeatNASDAQ:DOXRead Insider Buying: Amdocs (NASDAQ:DOX) Director Purchases $102,239.47 in Stock20 minutes agoTriSalus Life Sciences (NASDAQ:TLSI) Director Purchases 50,000 Shares of Company StockMarketBeatNASDAQ:TLSIRead TriSalus Life Sciences (NASDAQ:TLSI) Director Purchases 50,000 Shares of Company Stock20 minutes agoInsider Buying: Donegal Group (NASDAQ:DGICA) Major Shareholder Acquires 7,500 Shares of StockMarketBeatNASDAQ:DGICARead Insider Buying: Donegal Group (NASDAQ:DGICA) Major Shareholder Acquires 7,500 Shares of Stock20 minutes agoCorMedix (NASDAQ:CRMD) Stock: Insider Joseph Todisco Buys 80,000 SharesMarketBeatNASDAQ:CRMDRead CorMedix (NASDAQ:CRMD) Stock: Insider Joseph Todisco Buys 80,000 Shares20 minutes agoExlService (NASDAQ:EXLS) Stock: Insider Rohit Kapoor Sells 100,000 SharesMarketBeatNASDAQ:EXLSRead ExlService (NASDAQ:EXLS) Stock: Insider Rohit Kapoor Sells 100,000 Shares20 minutes agoHubSpot (NYSE:HUBS) Stock: Insider Brian Halligan Acquires 22,985 SharesMarketBeatNYSE:HUBSRead HubSpot (NYSE:HUBS) Stock: Insider Brian Halligan Acquires 22,985 Shares21 minutes agoCeva (NASDAQ:CEVA) Raised to Buy at CfraMarketBeatNASDAQ:CEVARead Ceva (NASDAQ:CEVA) Raised to Buy at Cfra21 minutes agoSolarEdge Technologies (NASDAQ:SEDG) Stock Price Target Cut by Wells Fargo & CompanyMarketBeatNASDAQ:SEDGRead SolarEdge Technologies (NASDAQ:SEDG) Stock Price Target Cut by Wells Fargo & Company21 minutes agoBullish (NYSE:BLSH) Price Target Cut to $28.00 by Analysts at Wells Fargo & CompanyMarketBeatNYSE:BLSHRead Bullish (NYSE:BLSH) Price Target Cut to $28.00 by Analysts at Wells Fargo & Company21 minutes agoCareTrust REIT (NYSE:CTRE) Stock Keeps "Market Outperform" Rating at Citizens JmpMarketBeatNYSE:CTRERead CareTrust REIT (NYSE:CTRE) Stock Keeps "Market Outperform" Rating at Citizens Jmp21 minutes agoEdwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Wells Fargo & Company Analyst SaysMarketBeatNYSE:EWRead Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says21 minutes agoHaemonetics (NYSE:HAE) Price Target Raised to $144.00MarketBeatNYSE:HAERead Haemonetics (NYSE:HAE) Price Target Raised to $144.0021 minutes agoSM Energy (NYSE:SM) Upgraded at Seaport Research PartnersMarketBeatNYSE:SMRead SM Energy (NYSE:SM) Upgraded at Seaport Research Partners21 minutes agoUnited Dominion Realty Trust (NYSE:UDR) Upgraded to "Outperform" at Zelman & AssociatesMarketBeatNYSE:UDRRead United Dominion Realty Trust (NYSE:UDR) Upgraded to "Outperform" at Zelman & Associates Featured Articles and OffersWhy Kinder Morgan's Chairman Just Bought $15 Million in StockBy Jeffrey Neal Johnson | November 10, 2026This Could Be the Biggest Monetary Shift in 50 YearsFrom Patriot Gold Group (Ad)Keeping AI Cool: AAON Rides the AI Heatwave to Record GrowthBy Jeffrey Neal Johnson | November 11, 2026Wall Street May Be Making a Big Mistake With monday.com StockBy Thomas Hughes | November 9, 20263 Insider Selling Stories; 3 Different Signals for InvestorsBy Thomas Hughes | November 11, 2026The investigation Porter spent tens of thousands to documentFrom Porter & Company (Ad)Don't Let Their Low Yields Fool You: 3 Dividend Stocks Worth WatchingBy Nathan Reiff | November 10, 2026D-Wave Quantum Has Long-Term Potential, But Is Now the Time to Buy?By Thomas Hughes | November 10, 2026 Alert CategoriesAll AlertsAnalystCongressional TradesConsensusCorporate BuybackCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Page 1 of 236 1234567 Earlier › Earliest » Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.